130 related articles for article (PubMed ID: 21388295)
1. Synergistic effects of arsenic trioxide and radiation in osteosarcoma cells through the induction of both autophagy and apoptosis.
Chiu HW; Lin W; Ho SY; Wang YJ
Radiat Res; 2011 May; 175(5):547-60. PubMed ID: 21388295
[TBL] [Abstract][Full Text] [Related]
2. Combination treatment with arsenic trioxide and irradiation enhances cell-killing effects in human fibrosarcoma cells in vitro and in vivo through induction of both autophagy and apoptosis.
Chiu HW; Lin JH; Chen YA; Ho SY; Wang YJ
Autophagy; 2010 Apr; 6(3):353-65. PubMed ID: 20200477
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide induces programmed cell death through stimulation of ER stress and inhibition of the ubiquitin-proteasome system in human sarcoma cells.
Chiu HW; Tseng YC; Hsu YH; Lin YF; Foo NP; Guo HR; Wang YJ
Cancer Lett; 2015 Jan; 356(2 Pt B):762-72. PubMed ID: 25449439
[TBL] [Abstract][Full Text] [Related]
4. Combination treatment with arsenic trioxide and irradiation enhances apoptotic effects in U937 cells through increased mitotic arrest and ROS generation.
Ho SY; Chen WC; Chiu HW; Lai CS; Guo HR; Wang YJ
Chem Biol Interact; 2009 May; 179(2-3):304-13. PubMed ID: 19159621
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH.
Han YH; Kim SZ; Kim SH; Park WH
Cancer Lett; 2008 Oct; 270(1):40-55. PubMed ID: 18539383
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB.
Wei LH; Lai KP; Chen CA; Cheng CH; Huang YJ; Chou CH; Kuo ML; Hsieh CY
Oncogene; 2005 Jan; 24(3):390-8. PubMed ID: 15531921
[TBL] [Abstract][Full Text] [Related]
7. Combination treatment with arsenic trioxide and irradiation enhances autophagic effects in U118-MG cells through increased mitotic arrest and regulation of PI3K/Akt and ERK1/2 signaling pathways.
Chiu HW; Ho SY; Guo HR; Wang YJ
Autophagy; 2009 May; 5(4):472-83. PubMed ID: 19242099
[TBL] [Abstract][Full Text] [Related]
8. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide.
Kanzawa T; Kondo Y; Ito H; Kondo S; Germano I
Cancer Res; 2003 May; 63(9):2103-8. PubMed ID: 12727826
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
[TBL] [Abstract][Full Text] [Related]
10. Realgar (As4S4) nanoparticles and arsenic trioxide (As2O3) induced autophagy and apoptosis in human melanoma cells in vitro.
Pastorek M; Gronesova P; Cholujova D; Hunakova L; Bujnakova Z; Balaz P; Duraj J; Lee TC; Sedlak J
Neoplasma; 2014; 61(6):700-9. PubMed ID: 25150315
[TBL] [Abstract][Full Text] [Related]
11. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH
Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: therapeutic potential for ovarian cancer.
Zhang N; Wu ZM; McGowan E; Shi J; Hong ZB; Ding CW; Xia P; Di W
Cancer Sci; 2009 Dec; 100(12):2459-64. PubMed ID: 19769630
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.
Wang Y; An R; Dong X; Pan S; Duan G; Sun X
Urol Int; 2009; 82(2):214-21. PubMed ID: 19322013
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of arsenic trioxide in transformed human thyroid cells.
Fröhlich E; Czarnocka B; Brossart P; Wahl R
Thyroid; 2008 Nov; 18(11):1183-93. PubMed ID: 19014326
[TBL] [Abstract][Full Text] [Related]
16. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
Zhao XS; Song PL; Sun B; Jiang HC; Liu TF
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):510-7. PubMed ID: 19822495
[TBL] [Abstract][Full Text] [Related]
18. Comparative investigations of sodium arsenite, arsenic trioxide and cadmium sulphate in combination with gamma-radiation on apoptosis, micronuclei induction and DNA damage in a human lymphoblastoid cell line.
Hornhardt S; Gomolka M; Walsh L; Jung T
Mutat Res; 2006 Aug; 600(1-2):165-76. PubMed ID: 16764896
[TBL] [Abstract][Full Text] [Related]
19. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor.
Lew YS; Kolozsvary A; Brown SL; Kim JH
Cancer Res; 2002 Aug; 62(15):4202-5. PubMed ID: 12154019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]